Tumour-cell-induced production of tumour necrosis factor by monocytes of gastric cancer patients receiving BCG immunotherapy.
Human peripheral blood monocytes cocultured with tumour cells were used as an in vitro model of in situ interactions between tumour-infiltrating macrophages and the tumour. Tumour cells stimulated de novo expression of the human tumour necrosis factor alpha (TNF) gene in monocytes and caused the release of TNF into the culture supernatant. A group of 14 patients with stage IVA gastric cancer receiving adjuvant chemotherapy (5-FU, Adriamycin, mitomycin C: FAM) or immunochemotherapy (BCG+FAM) was investigated for the ability of monocytes to produce TNF in vitro upon stimulation with tumour cells or purified protein derivative of tuberculin (PPD). Patients were followed at biweekly intervals, i.e. before each instillation of BCG epicutaneously over a period of 10 weeks. It was found that monocytes of some patients receiving BCG at the end of the observation period had an enhanced ability to produce TNF following stimulation with tumour cells. In contrast, such production was not substantially altered during the study period in patients on chemotherapy. PPD-induced TNF production was much weaker and was not significantly changed during this observation time. We infer that BCG immunotherapy may induce the subtle changes in some cancer patients that lead to an increased interaction between monocytes and tumour cells and result in enhanced production of cytokine(s) with antitumour properties.
Zembala
M
M
Department of Clinical Immunology, N. Copernicus Medical School, Cracow, Poland.
Czupryna
A
A
Wieckiewicz
J
J
Jasinski
M
M
Pryjma
J
J
Ruggiero
I
I
Siedlar
M
M
Popiela
T
T
D001500:BCG Vaccine / Q000627:therapeutic use*; D015870:Gene Expression; D006801:Humans; D007167:Immunotherapy; D009000:Monocytes / Q000378:metabolism*; D009369:Neoplasms / Q000378:metabolism*; D013274:Stomach Neoplasms / Q000097:blood* / Q000628:therapy; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis* / Q000235:genetics
D001500:BCG Vaccine; D014409:Tumor Necrosis Factor-alpha